Seqirus, part of the CSL Group, is the new global company created from the combined strength and expertise of bioCSL and the influenza vaccines business formerly owned by Novartis.
The Liverpool City Region Growth Strategy: Building our Future, acts as the City Region’s Strategic Economic Plan, outlining our ambitions for economic growth over the next 25 years. Our focus is economic growth that will ensure all our residents have the opportunity for a good quality of life for themselves as well future generations.
Our vision is the build on our core strengths and capacity for innovation to create a truly global and competitive City Region at the heart of the Northern Powerhouse.
Proposed interventions will lead to new jobs, new opportunities and improved prosperity, they are reflected in the following ambitions: